RVNC – revance therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Investors in Revance Therapeutics, Inc. Should Contact Levi & Korsinsky Before March 4, 2025 to Discuss Your Rights - RVNC
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm Encourages Revance Therapeutics, Inc. (RVNC) Investors To Inquire About Securities Fraud Class Action
Law Offices of Howard G. Smith Encourages Revance Therapeutics, Inc. (RVNC) Investors To Inquire About Securities Fraud Class Action
Investors in Revance Therapeutics, Inc. Should Contact Levi & Korsinsky Before March 4, 2025 to Discuss Your Rights - RVNC
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Revance Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - RVNC
Form SCHEDULE 13D/A Revance Therapeutics, Filed by: Teoxane SA
Form 4 Revance Therapeutics, For: Dec 31 Filed by: Schilke Tobin
Form 4 Revance Therapeutics, For: Dec 31 Filed by: Foley Mark J
Form SC TO-T/A Revance Therapeutics, Filed by: Crown Laboratories, Inc.
Form SC 14D9/A Revance Therapeutics, Filed by: Revance Therapeutics, Inc.
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.